Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.30 | -$0.14 | -$0.23 |
| Q2 2026 | 3 | -$0.70 | -$0.46 | -$0.58 |
| Q3 2026 | 3 | -$0.60 | -$0.35 | -$0.44 |
| Q4 2026 | 1 | -$0.43 | -$0.34 | -$0.38 |
| Q1 2027 | 1 | -$0.53 | -$0.42 | -$0.46 |
| Q2 2027 | 1 | -$0.45 | -$0.36 | -$0.40 |
| Q3 2027 | 1 | -$0.24 | -$0.19 | -$0.21 |
| Q4 2027 | 1 | -$0.34 | -$0.27 | -$0.30 |
| Q1 2028 | 1 | -$0.82 | -$0.65 | -$0.72 |
| Q2 2028 | 1 | -$0.61 | -$0.49 | -$0.54 |
| Q3 2028 | 1 | $0.05 | $0.07 | $0.06 |
NeuroOne Medical Technologies Corp last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.25 earnings per share for the quarter, missing analysts' consensus estimates of $-0.22667 by $0.02333. The company had revenue of 2.39 M for the quarter and had revenue of 12.10 M for the year. NeuroOne Medical Technologies Corp has generated $-1 earnings per share over the last year ($-0.54 diluted earnings per share) and currently has a price-to-earnings ratio of -3.74. NeuroOne Medical Technologies Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q2 2026 | -$0.23 | -$0.25 | -0.02 | $2.58 M | $2.39 M |
| 02/17/2026 | Q1 2026 | -$0.24 | -$0.17 | 0.07 | $2.66 M | $2.89 M |
| 12/16/2025 | Q4 2025 | -$0.04 | -$0.26 | -0.22 | $2.47 M | $2.74 M |
| 08/14/2025 | Q3 2025 | -$0.05 | -$0.19 | -0.14 | $1.82 M | $1.70 M |
| 05/13/2025 | Q2 2025 | -$0.09 | -$0.44 | -0.35 | $1.27 M | $1.39 M |
| 02/12/2025 | Q1 2025 | -$0.10 | $0.35 | 0.45 | $2.10 M | $3.27 M |
| 12/17/2024 | Q4 2024 | -$0.09 | $2.04 | 2.13 | $1.80 M | $272.28 K |
| 08/14/2024 | Q3 2024 | -$0.09 | -$0.60 | -0.51 | $1.50 M | $825.78 K |
| 05/14/2024 | Q2 2024 | -$0.09 | -$0.66 | -0.57 | $1.20 M | $1.38 M |
| 02/13/2024 | Q1 2024 | -$0.14 | -$0.84 | -0.7 | N/A | $977.65 K |
| 12/15/2023 | Q4 2023 | N/A | -$0.78 | N/A | N/A | $741.78 K |
| 08/14/2023 | Q3 2023 | -$0.21 | -$1.20 | -1 | N/A | $629.91 K |
| 05/12/2023 | Q2 2023 | N/A | -$1.26 | N/A | N/A | $466.18 K |
| 02/13/2023 | Q1 2023 | -$0.16 | -$0.66 | -0.51 | N/A | $114.58 K |
| 12/21/2022 | Q4 2022 | -$0.11 | -$0.51 | -0.4 | N/A | $68.79 K |
| 08/11/2022 | Q3 2022 | -$0.23 | -$1.02 | -0.8 | N/A | $32.05 K |
| 05/12/2022 | Q2 2022 | -$0.20 | -$1.14 | -0.94 | N/A | $36.58 K |
| 02/14/2022 | Q1 2022 | -$0.19 | -$1.08 | -0.9 | N/A | $33.75 K |
| 12/15/2021 | Q4 2021 | -$0.24 | -$1.32 | -1.09 | N/A | $48.34 K |
| 08/13/2021 | Q3 2021 | N/A | -$1.50 | N/A | N/A | $40.10 K |
The conference call for NeuroOne Medical Technologies Corp's latest earnings report can be listened to online.
The conference call transcript for NeuroOne Medical Technologies Corp's latest earnings report can be read online.
NeuroOne Medical Technologies Corp (:NMTC) has a recorded annual revenue of $12.10 M.
NeuroOne Medical Technologies Corp (:NMTC) has a recorded net income of $-3,605,374.NeuroOne Medical Technologies Corp has generated $-0.54 earnings per share over the last four quarters.
NeuroOne Medical Technologies Corp (:NMTC) has a price-to-earnings ratio of -3.74 and price/earnings-to-growth ratio is 0.04.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED